The presence of anti-Tat antibodies in HIV-infected individuals is associated with containment of CD4+ T-cell decay and viral load, and with delay of disease progression: results of a 3-year cohort study
about
Approaches to preventative and therapeutic HIV vaccinesBiocompatible anionic polymeric microspheres as priming delivery system for effetive HIV/AIDS Tat-based vaccinesThe Startling Properties of Fibroblast Growth Factor 2: How to Exit Mammalian Cells without a Signal Peptide at HandChallenges in HIV Vaccine Research for Treatment and Prevention.HIV-1 Tat immunization restores immune homeostasis and attacks the HAART-resistant blood HIV DNA: results of a randomized phase II exploratory clinical trialAssociation between different anti-Tat antibody isotypes and HIV disease progression: data from an African cohortIntradermal injection of a Tat Oyi-based therapeutic HIV vaccine reduces of 1.5 log copies/mL the HIV RNA rebound median and no HIV DNA rebound following cART interruption in a phase I/II randomized controlled clinical trial.Absolute quantification of HTLV-1 basic leucine zipper factor (HBZ) protein and its plasma antibody in HTLV-1 infected individuals with different clinical status.HIV-Tat immunization induces cross-clade neutralizing antibodies and CD4(+) T cell increases in antiretroviral-treated South African volunteers: a randomized phase II clinical trialA HIV-Tat/C4-binding protein chimera encoded by a DNA vaccine is highly immunogenic and contains acute EcoHIV infection in mice.Molecular and Genetic Characterization of HIV-1 Tat Exon-1 Gene from Cameroon Shows Conserved Tat HLA-Binding Epitopes: Functional Implications.HIV-1 vaccine immunogen design strategies.Development of a novel AIDS vaccine: the HIV-1 transactivator of transcription protein vaccine.HIV-Tat Protein Forms Phosphoinositide-dependent Membrane Pores Implicated in Unconventional Protein SecretionEffects of different routes of administration on the immunogenicity of the Tat protein and a Tat-derived peptide."cART intensification by the HIV-1 Tat B clade vaccine: progress to phase III efficacy studies".Reduced intraepidermal nerve fibre density, glial activation, and sensory changes in HIV type-1 Tat-expressing female mice: involvement of Tat during early stages of HIV-associated painful sensory neuropathy.
P2860
Q26764851-4683B02A-8188-40F6-8FCA-A8AE1BD0B344Q27333734-AB9CEE64-5AD2-49E6-AE69-FA101A1AB792Q28085435-B290BB14-F69A-4D58-92A5-2C0A564DA4F0Q34148683-F7FE0786-1441-459C-B8B3-5165F53F2A9CQ35552889-71FA8808-AFD5-45E6-8752-1A4E649EA7AEQ36083803-3DA36AE5-23F2-4B2A-A5CA-1891165EB834Q36758540-AADC9058-A776-44C6-A79B-76712127CCA2Q36842571-6E4020F7-6222-438D-B39A-81924F250E14Q36986644-C97CF71A-D107-4E6C-83DD-E25F6A4F24FFQ37054470-A5038C82-C0A0-4295-9051-940CCB7E2EF5Q37153763-D9644416-6093-494D-A0C3-41BBEED5E989Q38330424-362344B9-52CA-47E2-B755-4E7FDDB01C7AQ38533881-906AA80C-C23C-4C77-BF39-8B1424C22AEDQ41578290-6C8561E8-BCFD-4298-9283-A127E82BCC77Q42061242-B9D0B16B-7CE0-4B4A-B37C-CC085ACCB946Q46698274-72BEEADC-1590-4DD5-B8B9-F0BDCF9C3542Q55315288-9491E2AB-06B7-4604-9145-80796E21F474
P2860
The presence of anti-Tat antibodies in HIV-infected individuals is associated with containment of CD4+ T-cell decay and viral load, and with delay of disease progression: results of a 3-year cohort study
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The presence of anti-Tat antib ...... sults of a 3-year cohort study
@ast
The presence of anti-Tat antib ...... sults of a 3-year cohort study
@en
type
label
The presence of anti-Tat antib ...... sults of a 3-year cohort study
@ast
The presence of anti-Tat antib ...... sults of a 3-year cohort study
@en
prefLabel
The presence of anti-Tat antib ...... sults of a 3-year cohort study
@ast
The presence of anti-Tat antib ...... sults of a 3-year cohort study
@en
P2093
P2860
P50
P356
P1433
P1476
The presence of anti-Tat antib ...... sults of a 3-year cohort study
@en
P2093
Angela Arancio
Antonella Tripiciano
Aurelio Cafaro
Carlo Torti
Cristina Mussini
Emanuele Focà
Francesco Mazzotta
Giovanni Di Perri
Guido Palamara
Laura Sighinolfi
P2860
P2888
P356
10.1186/1742-4690-11-49
P50
P577
2014-06-24T00:00:00Z
P5875
P6179
1003364799